Tyler Lambing (@tylerlambingmd) 's Twitter Profile
Tyler Lambing

@tylerlambingmd

Tx ID, Post things I learn. Views my own

ID: 1196992454777589760

calendar_today20-11-2019 03:23:45

30 Tweet

38 Takipçi

65 Takip Edilen

Tyler Lambing (@tylerlambingmd) 's Twitter Profile Photo

Higher rates of Tx success for M. absecssus subsp. massiliense vs subsp. abscessus thought be 2/2 to presence of non functional erm41 gene in massiliense DOI: 10.1164/rccm.201003-0395OC

Tyler Lambing (@tylerlambingmd) 's Twitter Profile Photo

Drug-drug interaction between clarithromycin and rifabutin leads to increased rifabutin levels and is associated with uveitis DOI: 10.1177/106002809502901114

Tyler Lambing (@tylerlambingmd) 's Twitter Profile Photo

IDSA currently rec daily tx rather than TIW tx for cavitary MAC as TIW tx has been associated with lower than expected sputum conversion rates atsjournals.org/doi/full/10.11…

Tyler Lambing (@tylerlambingmd) 's Twitter Profile Photo

Younger tx recipient age associated with increased rates of rejection: thought to be 2/2 to decreased med adherence, T cell changes that come with aging pubmed.ncbi.nlm.nih.gov/26965071/

Tyler Lambing (@tylerlambingmd) 's Twitter Profile Photo

For pulm M. Kansaii tx- fixed 12 months of tx may be enough instead of 12 mo beyond culture conversion. Pooled data from 3 studies only found recurrence rate of ~ 5%. academic.oup.com/cid/article/do…

Tyler Lambing (@tylerlambingmd) 's Twitter Profile Photo

Continuing 2020 IDSA NTM guidelines: for M. abscessus pulm disease, if macrolide sensitive rec 3 drug regimen, for macrolide resistance recommend 4 drug regimen

Tyler Lambing (@tylerlambingmd) 's Twitter Profile Photo

Up to 90% of people receiving MAC treatment may experience treatment-emergent adverse events pubmed.ncbi.nlm.nih.gov/30216086/

Tyler Lambing (@tylerlambingmd) 's Twitter Profile Photo

CDC recommends for those that are vaccinated and then develop COVID-19 that it should not affect treatment decisions such as monoclonal antibodies cdc.gov/vaccines/covid…

Tyler Lambing (@tylerlambingmd) 's Twitter Profile Photo

Cochrane review: CMV Ig did not reduce risk in SOT when used for CMV ppx. Wide variability in results for various studies though - may be 2/2 to heterogenicity of the precipitants across studies (tx type, immunosuppression) PMID: 17443573

Tyler Lambing (@tylerlambingmd) 's Twitter Profile Photo

Secondary ppx for nocardia can be considered but no strong evidence. Hesitation given ⬇️ efficacy of low dose TMP/SMX for primary ppx.

Tyler Lambing (@tylerlambingmd) 's Twitter Profile Photo

FDA now saying you can do 5 doses (a 2nd booster) for COVID in SOT patients, 4 months after first booster fda.gov/news-events/pr…